The relationship between the CYP19 alleles rs727479A/C, rs700518A/G, and rs700519C/T and pregnancy outcome after assisted reproductive technology in patients with polycystic ovary syndrome in a Chinese population: A population‐based study
Authors:
Open Access
- 14 July 2017
- journal article
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 33 (11) , 558-566
Abstract
This study investigated the relationship between the CYP19 alleles, rs727479A/C, rs700518A/G, and rs700519C/T, and pregnancy outcome after assisted reproductive technology (ART) in patients with polycystic ovary syndrome (PCOS). Between January 2012 and September 2015, 293 PCOS patients undergoing ART were randomly selected for the study. According to pregnancy outcome after ART, the patients were assigned to pregnancy and non‐pregnancy groups. CYP19 rs727479A/C, rs700518A/G and rs700519C/T genotypes were determined using the denaturing high‐performance liquid chromatography (DHPLC) method. Haplotype frequencies of the CYP19 alleles rs727479A/C, rs700518A/G and rs700519C/T were estimated using the SHEsis platform. Logistic regression analysis was employed to analyze the factors influencing the pregnancy outcome after ART. The frequency of the AC + CC genotype of rs727479A/C was higher in the pregnancy group than in the non‐pregnancy group. The frequency of the CT + TT genotype of rs700519A/G was also higher in the pregnancy group than in the non‐pregnancy group. Haplotype analysis indicated that the AAC and AGT haplotypes both exhibited unfavorable influence on the pregnancy outcome after ART. The AAT and CGT haplotypes were favorable to the pregnancy outcome after ART. Logistic regression analysis suggested that the rs727479A/C AA genotype, the rs700519C/T CC genotype and body mass index (BMI) might exert unfavorable influence on the pregnancy outcome after ART for PCOS patients. These findings indicated that the CYP19 alleles rs727479A/C and rs700519C/T might be associated with the pregnancy outcome after ART in patients with PCOS.Keywords
Funding Information
- Fondazione ART per la Ricerca sui Trapianti
This publication has 39 references indexed in Scilit:
- Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER (+) breast cancerBone, 2013
- Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulationFertility and Sterility, 2013
- Haplotype structures and functional polymorphic variants of the drug target enzyme aromatase (CYP19A1) in South Indian populationMedical Oncology, 2013
- Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozoleBreast Cancer Research and Treatment, 2012
- Aromatase (CYP19) gene variants influence ovarian response to standard gonadotrophin stimulationJournal of Assisted Reproduction and Genetics, 2011
- A common polymorphism in the human aromatase gene alters the risk for polycystic ovary syndrome and modifies aromatase activity in vitroMolecular Human Reproduction, 2011
- Association between CYP19 gene SNP rs2414096 Polymorphism and polycystic ovary syndrome in Chinese womenBMC Medical Genetics, 2009
- Two Estrogen-Related Variants in CYP19A1 and Endometrial Cancer Risk: A Pooled Analysis in the Epidemiology of Endometrial Cancer ConsortiumCancer Epidemiology, Biomarkers & Prevention, 2009
- The interface between assisted reproductive technologies and genetics: technical, social, ethical and legal issuesEuropean Journal of Human Genetics, 2006
- Alternatively Spliced Transcripts of the Aromatase Cytochrome P450 (CYP19) Gene in Adipose Tissue of WomenThe Journal of Clinical Endocrinology & Metabolism, 1997